BSG005

Biosergen AS · Phase 1 active Small molecule

At a glance

Generic name	BSG005
Also known as	Polyene Macrolide
Sponsor	Biosergen AS
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection (PHASE1, PHASE2)
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005. (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BSG005 CI brief — competitive landscape report
BSG005 updates RSS · CI watch RSS
Biosergen AS portfolio CI